The available citation indicates a study evaluating the utility of an electronic frailty index in cancer patients receiving chemotherapy, published online in the British Journal of Cancer on 10 April 2026. The provided content does not include study design details, populations, methods, outcomes, effect sizes, or conclusions.
Consequently, specific results or implications for clinical practice cannot be stated from the provided material. As the source content is limited to bibliographic metadata (title, journal, online publication date, and DOI) without substantive data, any uncertainty about applicability or findings remains unresolved.
If additional details from the article (such as cohort characteristics, statistical associations between frailty index and chemotherapy tolerance, toxicity, survival, or treatment modifications) are supplied, a concise evidence-based synthesis could be generated.
British Journal of Cancer published a clinical update in Oncology on 10 Apr 2026.
The item focuses on The utility of electronic frailty index in cancer patients undergoing chemotherapy.
Review the original article for the full source wording and details.